Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24738598)

1.

Coexistence of three variants of cutaneous mastocytosis as the presenting sign of systemic mastocytosis with somatic c-kit D816V point mutation.

Lesnoni La Parola I, Cannistraci C, Izzi S, Pisani F, Amantea A, Rongioletti F.

Int J Dermatol. 2014 Oct;53(10):1265-8. doi: 10.1111/ijd.12182. Epub 2014 Apr 16. No abstract available.

PMID:
24738598
2.

[Clinical observations in cutan mastocytosis].

Mihalik N, Hidvégi B, Hársing J, Várkonyi J, Csomor J, Kovalszky I, Marschalkó M, Kárpáti S.

Orv Hetil. 2013 Sep 15;154(37):1469-75. doi: 10.1556/OH.2013.29702. Hungarian.

PMID:
24016753
3.

Mastocytosis and related disorders.

Chiu A, Orazi A.

Semin Diagn Pathol. 2012 Feb;29(1):19-30. Review.

PMID:
22372203
4.

[Anaphylactoid reaction in occult systemic mastocytosis. A rare dermatologic emergency ].

Ständer H, Beier K, Metze D, Brehler R.

Hautarzt. 2005 Mar;56(3):265-9. German.

PMID:
15619082
5.

[Mastocytosis: revisited with new cytogenetic data].

Vaes M, Vereecken P, de Wind R, Andry G, Li R, Bron D.

Rev Med Brux. 2012 Jan-Feb;33(1):12-21. Review. French.

PMID:
22512145
6.

The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.

De Matteis G, Zanotti R, Colarossi S, De Benedittis C, Garcia-Montero A, Bonifacio M, Sartori M, Aprili F, Caruso B, Paviati E, Carli G, Perbellini O, Zamò A, Bonadonna P, Pizzolo G, Guidi G, Martinelli G, Soverini S.

Leuk Res. 2015 Mar;39(3):273-8. doi: 10.1016/j.leukres.2014.11.029. Epub 2014 Dec 6.

PMID:
25582384
7.

Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.

Kristensen T, Vestergaard H, Møller MB.

J Mol Diagn. 2011 Mar;13(2):180-8. doi: 10.1016/j.jmoldx.2010.10.004.

8.

Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.

Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP.

J Mol Diagn. 2008 Jan;10(1):58-66. doi: 10.2353/jmoldx.2008.070061. Epub 2007 Dec 28. Erratum in: J Mol Diagn. 2009 May;10(3):276.

9.

[Systemic mastocytosis: bone impact].

Spivacow FR, Sarli M, Nakutny R.

Medicina (B Aires). 2012;72(3):201-6. Spanish.

10.

Diagnostic challenge in a patient with severe pruritic rash.

Manea I, Ailenei E, Candrea E, Dima D, Deleanu D.

Ann Allergy Asthma Immunol. 2015 Jan;114(1):65-7. doi: 10.1016/j.anai.2014.10.009. Epub 2014 Nov 18. No abstract available.

PMID:
25457869
11.

Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.

Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB; Mastocytosis Centre Odense University Hospital (MastOUH).

Eur J Haematol. 2012 Jul;89(1):42-6. doi: 10.1111/j.1600-0609.2012.01789.x. Epub 2012 Apr 28.

PMID:
22469616
12.

Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?

Lange M, Żawrocki A, Nedoszytko B, Wasąg B, Niedoszytko M, Jassem E, Nowicki R, Żmijewski MA, Biernat W.

Int Arch Allergy Immunol. 2014;165(2):104-10. doi: 10.1159/000368799. Epub 2014 Nov 15.

PMID:
25402852
13.

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.

Erben P, Schwaab J, Metzgeroth G, Horny HP, Jawhar M, Sotlar K, Fabarius A, Teichmann M, Schneider S, Ernst T, Müller MC, Giehl M, Marx A, Hartmann K, Hochhaus A, Hofmann WK, Cross NC, Reiter A.

Ann Hematol. 2014 Jan;93(1):81-8. doi: 10.1007/s00277-013-1964-1. Epub 2013 Nov 27.

PMID:
24281161
14.

KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis.

Broesby-Olsen S, Kristensen T, Vestergaard H, Brixen K, Møller MB, Bindslev-Jensen C; Mastocytosis Centre Odense University Hospital (MastOUH).

J Allergy Clin Immunol. 2013 Sep;132(3):723-8. doi: 10.1016/j.jaci.2013.02.019. Epub 2013 Apr 12.

PMID:
23587333
15.

[Case of systemic mastocytosis with hemophagocytic syndrome].

Watanabe A, Takahashi N, Yoshioka T, Miura I, Sawada K.

Nihon Naika Gakkai Zasshi. 2003 May 10;92(5):874-6. Japanese. No abstract available.

PMID:
12808914
16.

[Mastocytosis. Main symptoms of cutaneous mastocytosis: urticaria pigmentosa].

Kolyvanos Naumann U, Käser L, Vetter W.

Praxis (Bern 1994). 2005 Sep 7;94(36):1373-9; quiz 1380. German. No abstract available.

PMID:
16190370
17.

Role of imatinib in the treatment of pediatric onset indolent systemic mastocytosis: a case report.

Agarwala MK, George R, Mathews V, Balasubramanian P, Thomas M, Nair S.

J Dermatolog Treat. 2013 Dec;24(6):481-3. doi: 10.3109/09546634.2013.802274. Epub 2013 May 30.

PMID:
23659595
18.

Mastocytosis: state of the art.

Horny HP, Sotlar K, Valent P.

Pathobiology. 2007;74(2):121-32. Review.

PMID:
17587883
19.

KIT D816V mutation detection: a comparative study using peripheral blood, bone marrow aspirate and bone marrow trephine samples for detection of KIT mutations in patients with systemic mastocytosis.

Agarwal R, McBean M, Hewitt C, Westerman DA.

Leuk Lymphoma. 2014 Sep;55(9):2202-3. doi: 10.3109/10428194.2013.876498. Epub 2014 Jan 28. No abstract available.

PMID:
24359244
20.

[Hypereosinophilia as the leading symptom in a patient with mastocytosis].

Musch E, Parwaresch R, Malek M, Chrissafidou A.

Med Klin (Munich). 2005 May 13;100(5):286-7. German. No abstract available.

PMID:
15902384
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk